10 Results

People

  1. Bhargava
    Bhargava
  2. Chen
    Chen
  3. Lal
    Lal
  4. Edelweiss
    Edelweiss
  5. Gerald
    Gerald
  6. Ross
    Ross
  7. Brogi
    Brogi
  8. Dogan
    Dogan
  9. Hameed
    Hameed
  10. Hanna
    Hanna

Groups

  1. Department of Pathology and Laboratory Medicine (5)
  2. Department of Medicine (2)
  3. GSK Faculty (2)
  4. Human Oncology and Pathogenesis Program (2)
  5. Solid Tumor Oncology Division (2)
  6. Tow Center for Developmental Oncology (TCDO) (2)
  7. Breast Medicine Service (1)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (1)
  9. Epidemiology Service (1)
  10. Epidemiology and Biostatistics (1)
  1. "chromogenic in situ hybridization"
Formats
  1. Journal Article (10)
Groups
  1. Department of Pathology and Laboratory Medicine (5)
  2. Department of Medicine (2)
  3. GSK Faculty (2)
  4. Human Oncology and Pathogenesis Program (2)
  5. Solid Tumor Oncology Division (2)
  6. Tow Center for Developmental Oncology (TCDO) (2)

More Groups

People
  1. Beiyun Chen (4)
  2. Rohit Bhargava (4)
  3. Priti Lal (3)
  4. Dara Ross (2)
  5. Marcia Edelweiss (2)
  6. William Gerald (2)

More People

Years
  1. 2025 (2)
  2. 2023 (1)
  3. 2019 (2)
  4. 2015 (1)
  5. 2005 (4)
Publications
  1. American Journal of Clinical Pathology (2)
  2. Modern Pathology (2)
  3. American Journal of Surgical Pathology (1)
  4. Cancer (1)
  5. Cancer Cytopathology (1)
  6. Diagnostic Molecular Pathology (1)

More Publications

Publishers
  1. Lippincott Williams & Wilkins (2)
  2. Nature Research (2)
  3. Oxford University Press (2)
  4. Elsevier Science, Inc. (1)
  5. John Wiley & Sons (1)
  6. SPIE (1)

More Publishers

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: A first-in-human, single-centre, phase 1 trial
    Journal Article

    Lou, E.; Choudhry, M. S.; Starr, T. K.; Folsom, T. D.; Bell, J.; Rathmann, B.; DeFeo, A. P.; Kim, J.; Slipek, N.; Jin, Z.; more...
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Evidence for unified assessment criteria of HER2 immunohistochemistry in colorectal carcinoma
    Journal Article

    Evans, M. G.; Krause, H. B.; Xiu, J.; Elliott, A.; Lou, E.; Ghani, H.; Yantiss, R. K.; Garcia-Buitrago, M.; Matsubara, Y.; Nakamura, Y.; more...
    Modern Pathology (2025)

    Fulltext@MSK | Save
  • CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study
    Journal Article

    Kang, E. Y.; Weir, A.; Meagher, N. S.; Farrington, K.; Nelson, G. S.; Ghatage, P.; Lee, C. H.; Riggan, M. J.; Bolithon, A.; Popovic, G.; more...
    Cancer (2023)

    Fulltext@MSK | Save
  • Automatic quantification of HER2 gene amplification in invasive breast cancer from chromogenic in situ hybridization whole slide images
    Journal Article

    Hossain, M. S.; Hanna, M. G.; Uraoka, N.; Nakamura, T.; Edelweiss, M.; Brogi, E.; Hameed, M. R.; Yamaguchi, M.; Ross, D. S.; Yagi, Y.
    Journal of Medical Imaging (2019)

    Fulltext@MSK | Save
  • HER2 assessment by bright-field dual in situ hybridization in cell blocks of recurrent and metastatic breast carcinoma
    Journal Article

    Edelweiss, M.; Sebastiao, A. P. M.; Oen, H.; Kracun, M.; Serrette, R.; Ross, D. S.
    Cancer Cytopathology (2019)

    Fulltext@MSK | Save
  • A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors
    Journal Article

    Carter, J. M.; Caron, B. L.; Dogan, A.; Folpe, A. L.
    American Journal of Surgical Pathology (2015)

    Fulltext@MSK | Save
  • Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH)
    Journal Article

    Bhargava, R.; Oppenheimer, O.; Gerald, W.; Jhanwar, S. C.; Chen, B.
    Diagnostic Molecular Pathology (2005)

    Fulltext@MSK | Save
  • Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification: Does it measure up to fluorescence in situ hybridization?
    Journal Article

    Bhargava, R.; Lal, P.; Chen, B.
    American Journal of Clinical Pathology (2005)

    Fulltext@MSK | Save
  • HER-2/neu and topoisomerase IIα gene amplification and protein expression in invasive breast carcinomas: Chromogenic in situ hybridization and immunohistochemical analyses
    Journal Article

    Bhargava, R.; Lal, P.; Chen, B.
    American Journal of Clinical Pathology (2005)

    Fulltext@MSK | Save
  • EGFR gene amplification in breast cancer: Correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations
    Journal Article

    Bhargava, R.; Gerald, W. L.; Li, A. R.; Pan, Q.; Lal, P.; Ladanyi, M.; Chen, B.
    Modern Pathology (2005)

    Fulltext@MSK | Save